Transactivation of the Interleukin-1 Alpha Promoter by Human T-cell Leukemia Virus

References

• March C. I., Mosley B., Larsen A., Cerretti D. P., Braedt G., Price V., Gillis S., Henney C. S., Kronheim S. R., Grahstein K., Conlon P. J., Hopp T. P., Cosman D. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985; 315: 641–647
   PubMed Web of Science ®Google Scholar
• Furutani Y., Notake M., Fukui T., Ohue M., Nomura H., Yamada M., Nakamura S. Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res. 1986; 14: 3167–3179
   PubMed Web of Science ®Google Scholar
• Clark B. D., Collins K. L., Gandy M. S., Webb A. C., Auron P. E. Genomic sequence for human prointer-leukin 1 beta: Possible evolution from a reverse transcribed prointerleukin 1 alpha gene. Nucleic Acids Res. 1986; 14: 7897–7914
   PubMed Web of Science ®Google Scholar
• Webb A. C., Collins K. L., Auron P. E., Eddy R. L., Nakai H., Byers M. G., Haley L. L., Henry W. M., Shows T. B. Interleukin-I gene (IL1) assigned to long arm of human chromosome 2. Lymphokine Rex 1986; 5: 77–85
   PubMedGoogle Scholar
• Auron P. E., Webb A. C. Interleukin-1: A gene expression system regulated at multiple levels. Eur. Cytokine New. 1994; 5: 573–592
   PubMed Web of Science ®Google Scholar
• Furutani Y. Molecular studies on interleukin-1 a. Eur. Cytokine Netw. 1994; 5: 533–538
   PubMed Web of Science ®Google Scholar
• Stevenson F. T., Bursten S. L., Fanton C., Locksley R. M., Lovett D. H. The 31-kDa precursor of interleukin 1 α is myristoylated on specific lysines within the 16-kDa N-terminal propiece. Proc. Natl. Acad. Sci. USA 1993; 90: 7245–7249
   PubMed Web of Science ®Google Scholar
• Kurt-Jones E. A., Beller D. I., Mizel S. B., Unanue E. R. Identification of a membrane-associated interleukin 1 in macrophages. Proc. Natl. Acad. Sci. USA 1985; 82: 1204–1208
   PubMed Web of Science ®Google Scholar
• Kobayashi Y., Yamamoto K., Saido T., Kawasaki H., Oppenheim J. J., Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 α. Proc. Natl. Acad. Sci. USA 1990; 87: 5548–5552
   PubMed Web of Science ®Google Scholar
• Smith J. W., II, Urba W. J., Curti B. D., Elwood L. J., Steis R. G., Janik J. E., Sharfman W. H., Miller L. L., Fenton R. G., Conlon K. C., Sznol M., Creekmore S. P., Wells N. F., Ruscetti F. W., Keller J. R., Hestdal K., Shimizu M., Rossio J., Alvord W. G., Oppenheim J. J., Longo D. L. The toxic and hematologic effects of interleukin-I alpha administered in a phase I trial to patients with advanced malignancies. J. Clin. Oncol. 1992; 10: 1141–1152
   PubMed Web of Science ®Google Scholar
• Crown J., Jakubowski A., Kemeny N., Gordon M., Gasparetto C., Wong G., Sheridan C., Toner G., Meisenberg B., Botet J., Applewhite J., Sinha S., Moore M., Kelsen D., Buhles W., Gabrilove J. A phase I trial of recombinant human interleukin-1 β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood 1991; 78: 1420–1427
   PubMed Web of Science ®Google Scholar
• Nemunaitis J., Appelbaum F. R., Lilleby K., Buhles W. C., Rosenfeld C., Zeigler Z. R., Shadduck R. K., Singer J. W., Meyer W., Buckner C. D. Phase I study of recombinant interleukin-1 β in patients undergoing autolo-gous bone marrow transplant for acute myelogenous leukemia. Blood 1994; 83: 3473–3479
   PubMed Web of Science ®Google Scholar
• Gowen M., Wood D. D., Ihrie E. J., McGuire M. K. B., Russel R. G. G. An interleukin I like factor stimulates bone resorption in vitro. Nature 1983; 306: 378–380
   PubMed Web of Science ®Google Scholar
• Sabatini M., Boyce B., Aufdemorte T., Bonewald L., Mundy G. R. Infusions of recombinant human interleukin 1 α and 1 β cause hypercalcemia in normal mice. Proc. Natl. Acad. Sci. USA 1988; 85: 5235–5239
   PubMed Web of Science ®Google Scholar
• Wong-Stall F., Gallo R. C. Human T-lym-photropic retroviruses. Nature 1985; 317: 395–403
   PubMed Web of Science ®Google Scholar
• Maruyama M., Shibuya H., Harada H., Hatakeyama M., Seiki M., Fujita T., Inoue J., Yoshida M., Taniguchi T. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell 1987; 48: 343–350
   PubMed Web of Science ®Google Scholar
• Inoue J., Seiki M., Taniguchi T., Tsuru S., Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986; 5: 2883–2888
   PubMed Web of Science ®Google Scholar
• Siekevitz M., Feinberg M. B., Holbrook N., Wong-Staal F., Greene W. C. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc. Natl. Acad. Sci. USA 1987; 84: 5389–5393
   PubMed Web of Science ®Google Scholar
• Miyatake S., Seiki M., Malefijt R. D., Heike T., Fujisawa J., Takebe Y., Nishida J., Shlomai J., Yokota T., Yoshida M., AraÌ K., Arai N. Activation of T cell-derived lym-phokine genes in T cells and fibroblasts: Effects of human T cell leukemia virus type I p40x protein and bovine papilloma virus encoded E2 protein. Nucleic Acids Res 1988; 16: 6547–6566
   PubMed Web of Science ®Google Scholar
• Mori N., Shirakawa F., Shimizu H., Murakami S., Oda S., Yamamoto K., Eto S. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: Evidence for the involvement of NF- k B. Blood 1994; 84: 2904–2911
   PubMed Web of Science ®Google Scholar
• Mori N., Murakami S., Oda S., Prager D., Eto S. Production of interleukin 8 in adult T-cell leukemia cells: Possible transactivation of the interleukin 8 gene by human T-cell leukemia virus type I tax. Cancer Res. 1995; 55: 3592–3597
   PubMed Web of Science ®Google Scholar
• Mori N., Gill P. S., Mougdil T., Murakami S., Eto S., Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996; 88: 1035–1045
   PubMed Web of Science ®Google Scholar
• Miyatake S., Seiki M., Yoshida M., Arai K. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol. Cell. Biol. 1988; 8: 5581–5587
   PubMed Web of Science ®Google Scholar
• Fuji M., Sassone-Corsi P., Verma I. M. c-fos promoter trans-activation by the tax' protein of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 1988; 85: 8526–8530
   PubMed Web of Science ®Google Scholar
• Fujii M., Niki T., Mori T., Matsuda T., Matsui M., Nomura N., Seiki M. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 1991; 6: 1023–1029
   PubMed Web of Science ®Google Scholar
• Alexandre C., Charnay P., Verrier B. Transactivation of Krox-20. Krox-24 1991; 6: 1851–1857, promoters by the HTLV-I Tax protein through common regulatory elements. Oncogene
   Google Scholar
• Ratner L. Regulation of expression of the c-sis proto-oncogene. Nucleic Acids Res. 1989; 17: 4101–4115
   PubMed Web of Science ®Google Scholar
• Duyao M. P., Kessler D. J., Spicer D. B., Bartholomew C., Cleveland J. L., Siekevitz M., Sonenshein G. E. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF K B. J. Biol. Chem. 1992; 267: 16288–16291
   PubMed Web of Science ®Google Scholar
• Lilienbaum A., Duc Dodon M., Alexandre C., Gazzolo L., Paulin D. Effect of human T-cell leukemia virus type I Tax protein on activation of the human vimentin gene. J. Virol. 1990; 64: 256–263
   PubMedGoogle Scholar
• Watanabe T., Yamaguchi K., Takatsuki K., Osame M., Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-I tax gene. J. Exp. Med. 1990; 172: 759–765
   PubMed Web of Science ®Google Scholar
• Ejima E., Rosenblatt J. D., Massari M., Quan E., Stephens D., Rosen C. A., Prager D. Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) Tax and HTLV-II Tax proteins. Blood 1993; 81: 1017–1024
   PubMed Web of Science ®Google Scholar
• Green J. E. trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene. Mol. Cell. Biol. 1991; 11: 4635–4641
   PubMed Web of Science ®Google Scholar
• Kim S.-J., Kehrl J. H., Burton J., Tendler C. L., Jeang K.-T., Danielpour D., Thevenin C., Kim K. Y., Spom M. B., Roberts A. B. Transactivation of the transforming growth factor β 1 (TGF-β 1) gene by human T lymphotropic virus type 1 Tax: A potential mechanism for the increased production of TGF-β1 in adult T cell leukemia. J. Exp. Med. 1990; 172: 121–129
   PubMed Web of Science ®Google Scholar
• Albrecht H., Shakhov A. N., Jongeneel C. V. trans activation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I Taxl protein. J. Virol. 1992; 66: 6191–6193
   PubMed Web of Science ®Google Scholar
• Tschachler E., Bohnlein E., Felzmann S., Reitz M. S., Jr. Human T-lymphotropic virus type I tax regulates the expression of the human lymphotoxin gene. Blood 1993; 81: 95–100
   PubMed Web of Science ®Google Scholar
• Mori N., Murakami S., Oda S., Eto S. Human T-cell leukemia virus type I Tax induces intracel-Mar adhesion molecule-I expression in T cells. Blood 1994; 84: 350–351
   PubMed Web of Science ®Google Scholar
• Sawada M., Suzumura A., Yoshida M., Marunouchi T. Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells. J. Virol. 1990; 64: 4002–4006
   PubMed Web of Science ®Google Scholar
• Jeang K.-T., Boros I., Brady J., Radonovich M., Khoury G. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J. Virol. 1988; 62: 4499–4509
   PubMed Web of Science ®Google Scholar
• Leung K., Nabel G. J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-k B-like factor. Nature 1988; 333: 776–778
   PubMed Web of Science ®Google Scholar
• Hoyos B., Ballard D. W., Bohnlein E., Siekevitz M., Greene W. C. Kappa B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression. Science 1989; 244: 457–460
   PubMed Web of Science ®Google Scholar
• Schreck R., Baeuerle P. A. NF-k B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 1990; 10: 1281–1286
   PubMed Web of Science ®Google Scholar
• Fujii M., Tsuchiya H., Chuhjo T., Akizawa T., Seiki M. Interaction of HTLV-1 Tax 1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 1992; 6: 2066–2076
   PubMed Web of Science ®Google Scholar
• Uchijima M., Sato H., Fujii M., Seiki M. Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding erythroid-potentiating activity (tissue inhibitor of metalloproteinases-1, TIMP-1). J. Biol. Chem. 1994; 269: 14946–14950
   PubMed Web of Science ®Google Scholar
• Dittmer J., Gitlin S. D., Reid R. L., Brady J. N. Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: Evidence for the involvement of transcription factor Ets 1. J. Virol. 1993; 67: 6087–6095
   PubMed Web of Science ®Google Scholar
• Jeang K.-T., Widen S. G., Semmes O. J., IV, Wilson S. H. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human P-polymerase gene. Science 1990; 247: 1082–1084
   PubMed Web of Science ®Google Scholar
• Uittenhogaard M. N., Giebler H. A., Reisman D., Nyborg J. K. Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J. Biol. Chern. 1995; 270: 28503–28506
   PubMed Web of Science ®Google Scholar
• Feigenbaum L., Fujita K., Collins F. S., Jay G. Repression of the NF1 gene by Tax may explain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice. J. Virol 1996; 70: 3280–3285
   PubMed Web of Science ®Google Scholar
• Uittenbogaard M. N., Armstrong A. P., Chiaramello A., Nyborg J. K. Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J. Biol. Chem. 1994; 269: 22466–22469
   PubMed Web of Science ®Google Scholar
• Zhao L.-J., Giam C.-Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA 1992; 89: 7070–7074
   PubMed Web of Science ®Google Scholar
• Wagner S., Green M. R. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 1993; 262: 395–399
   PubMed Web of Science ®Google Scholar
• Armstrong A. P., Franklin A. A., Uittenbogaard M. N., Giebler H. A., Nyborg J. K. Proc. Natl. Acad. Sci. USA 1993; 90: 7303–7307, Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors.
   PubMed Web of Science ®Google Scholar
• Anderson M. G., Dynan W. S. Quantitative studies of the effect of HTLV-I Tax protein on CREB pro-tein-DNA binding. Nucleic Acids Res. 1994; 22: 3194–3201
   PubMed Web of Science ®Google Scholar
• Mod N., Prager D. High levels of AP-Zbinding activity in cell lines infected with human T-cell leukemia virus type I: Possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax. Cancer Res. 1996; 56: 779–782
   PubMed Web of Science ®Google Scholar
• Baranger A. M., Palmer C. R., Hamm M. K., Giebler H. A., Brauweiler A., Nyborg J. K., Schepartz A. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature 1995; 376: 606–608
   PubMed Web of Science ®Google Scholar
• Grassmann R., Berchtold S., Radant I., Alt M., Fleckenstein B., Sodroski J. G., Haseltine W. A., Ramstedt U. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 1992; 66: 4570–4575
   PubMed Web of Science ®Google Scholar
• Grossman W. J., Kimata J. T., Wong F.-H., Zutter M., Ley T. J., Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 1995; 92: 1057–1061
   PubMed Web of Science ®Google Scholar
• Hidaka M., Inoue J., Yoshida M., Seiki M. Post-transcriptionai regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 1988; 7: 519–523
   PubMed Web of Science ®Google Scholar
• Kiyokawa T., Seiki M., Iwashita S., Imagawa K., Shimizu F., Yoshida M. p27X-III and p2lX-III proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 1985; 82: 8359–8563
   PubMed Web of Science ®Google Scholar
• Kanamori H., Suzuki N., Siomi H., Nosaka T., Sato A., Sabe H., Hatanaka M., Honjo T. HTLV-1 p27rex stabilizes human interleukin-2 receptor α chain mRNA. EMBOJ. 1990; 9: 4161–4166
   PubMed Web of Science ®Google Scholar
• Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980; 77: 7415–7419
   PubMed Web of Science ®Google Scholar
• Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 1982; 79: 2031–2035
   PubMed Web of Science ®Google Scholar
• Kondo T., Nonaka H., Miyamoto N., Yoshida R., Matsue Y., Ohguchi Y., Inouye H., Komoda H., Hinuma Y., Hanaoka M. Incidence of adult T-cell leukemia-lym-phoma and its familial clustering. Int. J. Cancer 1985; 35: 749–751
   PubMed Web of Science ®Google Scholar
• Tajima K., Tominaga S., Suchi T., Kawagoe T., Komoda H., Hinuma Y., Oda T., Fujita K. Epidemio-logical analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: Possible horizontal transmission of adult T-cell leukemia virus. Jpn. J. Cancer Res. 1982; 73: 893–901
   Google Scholar
• Murphy E. L., Hanchard B., Figueroa J. P., Gibbs W. N., Lofters W. S., Campbell M., Goedert J. J., Blather W. A. Modelling the risk of adult T-cell leukemia/lym-phoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer 1989; 43: 250–253
   PubMed Web of Science ®Google Scholar
• Seiki M., Eddy R., Shows T. B., Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia cells. Nature 1984; 309: 640–642
   PubMed Web of Science ®Google Scholar
• Kim J. H., Durack D. T. Manifestations of human T-lymphotropic virus type I infection. Am. J. Med. 1988; 84: 919–928
   PubMed Web of Science ®Google Scholar
• Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., De The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; 1: 441
   PubMed Web of Science ®Google Scholar
• Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miyata N. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 1992; 83: 236–239
   PubMedGoogle Scholar
• Sugimoto M., Nakashima H., Watanabe S., Uyama E., Tanaka F., Ando M., Araki S., Kawasaki S. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; 2: 1220
   PubMed Web of Science ®Google Scholar
• Lagrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancer 1990; 336: 1345–1347
   PubMed Web of Science ®Google Scholar
• Kalyanaraman V. S., Samgadharan M. G., Robert-Guroff M., Miyoshi I., Blayney D., Golde D., Gallo R. C. A new subtype of human T-cell leukemia virus (HTLV-11) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571–573
   PubMed Web of Science ®Google Scholar
• Rosenblatt J. D., Golde D. W., Wachsman W., Giorai J. V., Jacobs A., Schmidt G. M., Quan S., Gasson J. C., Chen I. S. Y. A second isolate of HTLV-II associated with atypical hairy cell leukemia. N. Engl. J. Med. 1986; 315: 372–377
   PubMed Web of Science ®Google Scholar
• Wano Y., Hattori T., Matsuoka M., Takatsuki K., Chua A. O., Gubler U., Greene W. C. Interleukin 1 gene expression in adult T cell leukemia. J. Clin. Invest. 1987; 80: 911–916
   PubMed Web of Science ®Google Scholar
• Kodaka T., Uchiyama T., Umadome H., Uchino H. Expression of cytokine mRNA in leukemic cells from adult T cell leukemia patients. Jpn. J. Cancer Res. 1989; 80: 531–536
   PubMedGoogle Scholar
• Yamashita U., Shirakawa F., Nakamura H. Production of interleukin 1 by adult T cell leukemia (ATL) cell lines. J. Immunol. 1987; 138: 3284–3289
   PubMed Web of Science ®Google Scholar
• Noma T., Nakakubo H., Sugita M., Kumagai S., Maeda M., Shimizu A., Honjo T. Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related. J. Exp. Med. 1989; 169: 1853–1858
   PubMed Web of Science ®Google Scholar
• Mori N., Shirakawa F., Murakami S., Oda S., Eto S. Interleukin-4 inhibits the production of interleukin-I by adult T-cell leukemia cells. Eur. J. Haematol. 1995; 55: 121–125
   PubMed Web of Science ®Google Scholar
• Maeda M., Shimizu A., Ikuta K., Okamoto H., Kashihara M., Uchiyama T., Honjo T., Yodoi J. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. J. Exp. Med. 1985; 162: 2169–2174
   PubMed Web of Science ®Google Scholar
• Mori N., Prager D. Transactivation of the interleukin-1 α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 1996; 87: 3410–3417
   PubMed Web of Science ®Google Scholar
• Ruben S. M., Perkins A., Rosen C. A. Activation of NF-k B by the HTLV-I trans-activator protein tax requires an additional factor present in lymphoid cells. NewBiol. 1989; 1: 275
   Google Scholar
• Bunn P. A., Jr, Schechter G. P., Jaffe E., Blayney D., Young R. C., Matthews M. J., Blattner W., Broder S., Robert-Guroff M., Gallo R. C. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N. Engl. J. Med. 1983; 309: 257–264
   PubMed Web of Science ®Google Scholar
• Catovski D., Greaves M. F., Rose M., Galton D. A. G., Goolden A. W. G., McCluskey D. R., White J. M., Lampert I., Bourikas G., Ireland R., Brownell A. I., Bridges J. M., Blattner W. A., Gallo R. C. Adult T-cell lymphoma-leukemia in blacks from the West Indies. Lancet 1982; 1: 639–643
   PubMed Web of Science ®Google Scholar
• Stashenko P., Dewhirst F. E., Peros W. J., Kent R. L., Ago J. M. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J. Immunol. 1987; 138: 1464–1468
   PubMed Web of Science ®Google Scholar
• Sato K., Fujii Y., Kasono K., Ozawa M., Imamura H., Kanaji Y., Kurosawa H., Tsushima T., Shizume K. Parathyroid hormone-related protein and interleukin-1 α synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice. in vivo. Endocrinology 1989; 124: 2172–2178
   PubMed Web of Science ®Google Scholar
• Shirakawa F., Yamashita U., Tanaka Y., Watanabe K., Sato K., Haratake J., Fujihira T., Oda S., Eto S. Production of bone-resorbing activity corresponding to inter-leukin-1 α by adult T-cell leukemia cells in humans. Cancer Res. 1988; 48: 4284–4287
   PubMed Web of Science ®Google Scholar
• Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1997; 50: 481–492
   Google Scholar
• Yamamoto S., Hattori T., Asou N., Nishimura H., Kawano F., Yodoi J., Takatsuki K. Absolute neutrophilia in adult T cell leukemia. Jpn. J. Cancer Res. 1986; 77: 858–861
   PubMedGoogle Scholar
• Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095–2147
   PubMed Web of Science ®Google Scholar
• Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajima I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M., Yamamoto H., Sekiguchi T. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991; 253: 1026–1028
   PubMed Web of Science ®Google Scholar
• Iwakura Y., Saijo S., Kioka Y., Nakayama-Yamada J., Itagaki K., Tosu M., Asano M., Kanai Y., Kakimoto K. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 1995; 155: 1588–1598
   PubMed Web of Science ®Google Scholar
• Sagawa K., Mochizuki M., Masuoka K., Katagiri K., Katayama T., Maeda T., Tanimoto A., Sugita S., Watanabe T., Itoh K. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis: Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J. Clin. Invest. 1995; 95: 852–858
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Svenson M., Jonsson V., Hippe E. Autoantihodies to cytokines—friends or foes?. Immunol. Today 1990; 11: 167–169
   PubMedGoogle Scholar
• Svenson M., Hansen M. B., Bendtzen K. Binding of cytokines to pharmaceutically prepared human immunoglobulin. J. Clin. Invest. 1993; 92: 2533–2539
   PubMed Web of Science ®Google Scholar
• Borth W., Urbanski A., Prohaska R., Susani M., Luger T. A. Binding of recombinant interleukin-1 β to the third complement component and α2--macroglobulin after activation of serum by immune complexes. Blood 1990; 75: 2388–2395
   PubMed Web of Science ®Google Scholar
• Arend W. P., Malyak M., Smith M. F., Jr, Whisenand T. D., Slack J. L., Sims J. E., Giri J. G., Dower S. K. Binding of IL-1 α, IL-I β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 1994; 153: 4766–4774
   PubMed Web of Science ®Google Scholar
• Furukawa Y., Osame M., Kubota R., Tara M., Yoshida M. Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic para-paresis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995; 85: 1865–1870
   PubMed Web of Science ®Google Scholar
• Hirai H., Fujisawa J., Suzuki T., Ueda K., Muramatsu M., Tsuboi A., Arai N., Yoshida M. Transcriptional activator Tax of HTLV-I binds to the NF- k B precursor p105. Oncogene 1992; 7: 1732–1742
   Google Scholar
• Suzuki T., Hirai H., Fujisawa J., Fujita T., Yoshida M. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF- k B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF- k B site and CArG box. Oncogene 1993; 8: 2391–2397
   PubMed Web of Science ®Google Scholar
• Wirai H., Suzuki T., Fujisawa J., Inoue J., Yoshida M. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor k B and induces nuclear translocation of transcription factor NF- k B proteins for transcriptional activation. Proc. Natl. Acad. Sci USA 1994; 91: 3584–3588
   PubMed Web of Science ®Google Scholar
• Suzuki T., Hirai H., Murakami T., Yoshida M. Tax protein of HTLV-1 destabilizes the complexes of NF-k B and I k B-α and induces nuclear translocation of NF- k B for transcriptional activation. Oncogene 1995; 10: 1199–1207
   PubMed Web of Science ®Google Scholar
• Kitajima I., Shinohara T., Bilakovics J., Brown D. A., Xu X., Nerenberg M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NK- kB. Science 1992; 258: 1792–1795
   PubMed Web of Science ®Google Scholar